SAN
FRANCISCO, Nov. 19, 2024 /PRNewswire/ -- Dolby
Laboratories, Inc. (NYSE:DLB) today announced the company's
financial results for the fourth quarter and fiscal year
2024.
"We are pleased with the progress we made in fiscal 2024," said
Kevin Yeaman, President and CEO,
Dolby Laboratories. "As we enter fiscal 2025, we have strong
momentum with Dolby Atmos and Dolby Vision, our imaging patent
portfolio has gotten stronger with the GE Licensing acquisition,
and we are excited about our opportunity with Dolby.io, which is
well positioned to provide real time interactive experiences for
sports and entertainment."
Fourth Quarter Fiscal 2024 Financial Highlights
- Total revenue was $305 million,
compared to $291 million for the
fourth quarter of fiscal 2023.
- GAAP net income was $59 million,
or $0.61 per diluted share, compared
to GAAP net income of $9 million, or
$0.09 per diluted share, for the
fourth quarter of fiscal 2023. On a non-GAAP basis, fourth quarter
net income was $78 million, or
$0.81 per diluted share, compared to
$64 million, or $0.65 per diluted share, for the fourth quarter
of fiscal 2023.
- Dolby repurchased approximately 251,000 shares of its common
stock and ended the quarter with approximately $402 million of stock repurchase authorization
available going forward.
Full Year Fiscal 2024 Financial Highlights
- Total revenue was $1.27 billion,
compared to $1.30 billion for the
full year of fiscal 2023.
- GAAP net income was $262 million,
or $2.69 per diluted share, compared
to GAAP net income of $201 million,
or $2.05 per diluted share, for the
full year of fiscal 2023. On a non-GAAP basis, full year net income
was $369 million, or $3.79 per diluted share, compared to $348 million, or $3.56 per diluted share, for the full year of
fiscal 2023.
- Cash flows from operations were $327
million, compared to $367
million for the full year of fiscal 2023.
A complete listing of Dolby's non-GAAP measures are described
and reconciled to the corresponding GAAP measures at the end of
this release.
Recent Business Highlights
- We closed the acquisition of GE Licensing, which we expect to
be accretive to margins and earnings on a non-GAAP basis in fiscal
2025, and which gives us a stronger position in imaging
patents.
- We acquired THEO Technologies, expanding Dolby.io's ability to
offer customers the best solutions for real-time streaming
experiences that drive fan engagement and interactivity.
- We added two new automotive partners in Q4; WEY, a Chinese car
company that specializes in premium Crossovers and SUVs, and Smart,
a JV between Mercedes and Geely. We now have over 20 automotive OEM
partners supporting Dolby Atmos, up from 10 partners one year
ago.
- Meta announced support for Dolby Atmos across its MetaQuest
headset device lineup.
- Apple launched the iPhone 16, which supports Dolby Atmos and
Dolby Vision, and records in Dolby Vision.
- Xiaomi announced new 4K QLED TVs
that support Dolby Vision.
- Australia selected Dolby AC-4
as part of its new broadcast set-top-box specification.
- Polytron, an Indonesian TV OEM, launched a new TV that supports
Dolby Atmos and Dolby Vision.
- Lenovo's new Thinkpad X1 Carbon Gen 13 Aura Edition supports
Dolby Vision, and its Thinkbook 16 Gen7+ and Thinkbook 16 Gen 7
supports Dolby Atmos.
- Alienware released 27 4K Dual
Resolution Gaming Monitor that supports Dolby Atmos.
Upcoming Investor Event
Dolby is hosting an event at CES for the financial community
where we will demonstrate a wide array of our technologies. The
event will be held at 7:00 a.m. PT on Wednesday, January 8, 2025. Please send an email
to IR@dolby.com for more information.
Dividend
Today, Dolby announced a cash dividend of $0.33 per share of Class A and Class B common
stock, payable on December 10, 2024, to stockholders of record
as of the close of business on December 3, 2024.
Revolving Credit Facility
On November 14, 2024, Dolby
entered into a Credit Agreement with Bank of America for a
$250 million revolving credit
facility. The facility includes $150
million of uncommitted incremental capacity, has a five-year
term and can be terminated early without penalty. Dolby has not
drawn on the facility. Further details regarding the Credit
Agreement are set out in a Form 8-K filed by Dolby with the U.S.
Securities and Exchange Commission on November 19, 2024.
Financial Outlook
Dolby's financial outlook relies, in part, on estimates of
royalty-based revenue that take into consideration various factors
that are subject to uncertainty, including consumer demand for
electronic products. In addition, actual results could differ
materially from the estimates Dolby is providing below due in part
to uncertainty resulting from the macroeconomic effect of certain
conditions, including supply chain constraints, international
conflicts, geopolitical instability, and fluctuations in inflation
and interest rates. The uncertainty resulting from these factors
has greatly reduced its visibility into Dolby's future outlook. To
the extent possible, the estimates Dolby is providing for future
periods reflect certain assumptions about the potential impact of
certain of these items, based upon a consideration of currently
available external and internal data and information. These
assumptions are subject to risks and uncertainties. For more
information, see "Forward-Looking Statements" in this press release
for a description of certain risks that Dolby faces, and the
section captioned "Risk Factors" in its Annual Report on Form 10-K
for fiscal 2024, to be filed on or around the date hereof.
Dolby is providing the following estimates for its first quarter
of fiscal 2025:
- Total revenue is estimated to range from $330 million to $360
million.
- Licensing revenue is estimated to range from $305 million to $335
million.
- Gross margins are anticipated to be approximately 87% on a GAAP
basis and approximately 90% on a non-GAAP basis.
- Operating expenses are anticipated to range from $230 million to $240
million on a GAAP basis and from $190
million to $200 million on a
non-GAAP basis.
- Effective tax rate is anticipated to be around 20.5% on a GAAP
basis and around 18.5% on a non-GAAP basis.
- Diluted earnings per share is anticipated to range from
$0.53 to $0.68 on a GAAP basis and from $0.96 to $1.11 on a
non-GAAP basis.
Dolby is providing the following estimates for the full year of
fiscal 2025:
- Total revenue is expected to range from $1.33 billion to $1.39
billion.
- Gross margins are anticipated to be approximately 87% on a GAAP
basis and approximately 90% on a non-GAAP basis.
- Operating expenses are anticipated to range from $908 million to $918
million on a GAAP basis and from $765
million to $775 million on a
non-GAAP basis.
- Dolby expects operating margins to be roughly 20% on a GAAP
basis and to be roughly 33% on a non-GAAP basis.
- Diluted earnings per share is anticipated to range from
$2.43 to $2.58 on a GAAP basis and from $3.99 to $4.14 on a
non-GAAP basis.
Conference Call Information
Members of Dolby management will lead a conference call open to
all interested parties to discuss fourth quarter and full year
fiscal 2024 financial results for Dolby Laboratories at
2:00 p.m. PT (5:00 p.m. ET) on Tuesday,
November 19, 2024. Access to the teleconference will be
available at http://investor.dolby.com or by dialing 1-800-715-9871
(+1-646-307-1963 for international callers) and entering
confirmation code 5587811.
A replay of the call will be available from 5:00 p.m. PT (8:00 p.m.
ET) on Tuesday, November 19,
2024, until 8:59 p.m. PT
(11:59 p.m. ET) on Tuesday, November 26, 2024 by dialing
1-800-770-2030 (+1-609-800-9909 for international callers) and
entering the confirmation code 5587811. An archived version of the
teleconference will also be available on the Dolby website,
http://investor.dolby.com.
Non-GAAP Financial Information
To supplement Dolby's financial statements presented on a GAAP
basis, Dolby management uses, and Dolby provides to investors,
certain non-GAAP financial measures as an additional tool to
evaluate Dolby's operating results in a manner that focuses on what
Dolby's management believes to be its ongoing business operations
and performance. We believe these non-GAAP financial measures are
also helpful to investors in enabling comparability of operating
performance between periods and among peer companies. Additionally,
Dolby's management regularly uses our supplemental non-GAAP
financial measures to make operating decisions, for planning and
forecasting purposes and determining bonus payouts. Specifically,
Dolby excludes the following as adjustments from one or more of its
non-GAAP financial measures:
Stock-based compensation expense: Stock-based
compensation, unlike cash-based compensation, utilizes subjective
assumptions in the methodologies used to value the various
stock-based award types that Dolby grants. These assumptions may
differ from those used by other companies. To facilitate more
meaningful comparisons between its underlying operating results and
those of other companies, Dolby excludes stock-based compensation
expense.
Amortization of acquisition-related intangibles: Dolby
amortizes intangible assets acquired in connection with business
combinations. These intangible assets consist of patents and
technology, customer relationships, and other intangibles. Dolby
records amortization charges relating to these intangible assets in
its GAAP financial statements, and Dolby views these charges as
items arising from pre-acquisition activities that are determined
by the timing and valuation of its acquisitions. As these
amortization charges do not directly correlate to its operations
during any particular period, Dolby excludes these charges to
facilitate an evaluation of its current operating performance and
comparisons to its past operating results. In addition, while
amortization expense of acquisition-related intangible assets is
excluded from Non-GAAP Net Income, the revenue generated from those
assets is not excluded.
Restructuring charges or credits: Restructuring
charges are costs associated with restructuring plans and primarily
relate to costs associated with exit or disposal activities,
employee severance benefits, and asset impairments. For the fourth
quarter of fiscal 2023, we excluded from non-GAAP net income and
diluted earnings per share a restructuring charge of about
$30 million comprised of
approximately $13 million for
severance and related benefits and an impairment loss of
approximately $17 million related
primarily to internally developed software for projects we are no
longer pursuing. Dolby excludes restructuring costs, including any
adjustments to charges recorded in prior periods (which may be
credits), as Dolby believes that these costs are not representative
of its normal operating activities and therefore, excluding these
amounts enables a more effective comparison of its past operating
performance and to that of other companies.
Income tax adjustments: The income tax effects of the
aforementioned non-GAAP adjustments do not directly correlate to
its operating performance so Dolby believes that excluding such
income tax effects provides a more meaningful view of its
underlying operating results to management and investors.
Impact from Tax Reform: The enactment of the U.S. Tax
Cuts and Jobs Act (Tax Reform), and any related amendments or
revisions, requires certain discrete and infrequent charges that
are not representative of current operating results and therefore,
excluding these amounts enables a more effective comparison to our
past operating performance.
Using the aforementioned adjustments, Dolby provides various
non-GAAP financial measures including, but not limited to: non-GAAP
net income, non-GAAP diluted earnings per share, non-GAAP gross
margin, non-GAAP operating expenses, non-GAAP operating margin, and
non-GAAP effective tax rate. Dolby's management believes it is
useful for itself and investors to review both GAAP and non-GAAP
measures to assess the performance of Dolby's business,
including as a means to evaluate period-to-period
comparisons. Dolby's management does not itself, nor does it
suggest that investors should, consider non-GAAP financial measures
in isolation from, superior to, or as a substitute for, financial
information prepared in accordance with GAAP. Whenever Dolby uses
non-GAAP financial measures, it provides a reconciliation of the
non-GAAP financial measures to the most closely applicable GAAP
financial measures. Investors are encouraged to review the related
GAAP financial measures and the reconciliation of these non-GAAP
financial measures to their most directly comparable GAAP financial
measures as detailed above and below. Investors are also encouraged
to review Dolby's GAAP financial statements as reported in its US
Securities and Exchange Commission (SEC) filings. A reconciliation
between GAAP and non-GAAP financial measures is provided at the end
of this press release and on the Dolby investor relations website,
http://investor.dolby.com.
Forward-Looking Statements
Certain statements in this press release and in our earnings
calls, including, but not limited to, expected financial results
for the first quarter of fiscal 2025 and full year fiscal 2025,
Dolby's ability to expand existing business, navigate challenging
periods, pursue its long-term growth opportunities, and advance its
other long-term objectives are "forward-looking statements" that
inherently involve substantial risks and uncertainties. These
forward-looking statements are based on management's current
expectations, and as a result of certain risks and uncertainties,
actual results may differ materially from those provided. The
following important factors, without limitation, could cause actual
results to differ materially from those in the forward-looking
statements: the potential impacts of economic conditions on Dolby's
business operations, financial results, and financial position
(including the impact to Dolby partners and disruption of the
supply chain and delays in shipments of consumer products; the
level at which Dolby technologies are incorporated into products
and the consumer demand for such products; delays in the
development and release of new products or services that contain
Dolby technologies; delays in royalty reporting or delinquent
payment by partners or licensees; lengthening sales cycles; the
impact to the overall cinema market including adverse impact to
Dolby's revenue recognized on box-office sales and demand for
cinema products and services; and macroeconomic conditions that
affect discretionary spending and access to products that contain
Dolby technologies); risks associated with geopolitical issues and
international conflicts; risks associated with trends in the
markets in which Dolby operates, including the broadcast, mobile,
consumer electronics, PC, and other markets; the loss of, or
reduction in sales by, a key customer, partner, or licensee;
pricing pressures; risks relating to changing trends in the way
that content is distributed and consumed; risks relating to
conducting business internationally, including trade restrictions
and changes in diplomatic or trade relationships; risks relating to
maintaining patent coverage; the timing of Dolby's receipt of
royalty reports and payments from its licensees, including
recoveries; changes in tax regulations; timing of revenue
recognition under licensing agreements and other contractual
arrangements; Dolby's ability to develop, maintain, and strengthen
relationships with industry participants; Dolby's ability to
develop and deliver innovative products and technologies in
response to new and growing markets; competitive risks; risks
associated with conducting business in China and other countries that have
historically limited recognition and enforcement of intellectual
property and contractual rights; risks associated with the health
of the motion picture and cinema industries generally; Dolby's
ability to increase its revenue streams and to expand its business
generally, and to continue to expand its business beyond its
current technology offerings; risks associated with acquiring and
successfully integrating businesses or technologies; and other
risks detailed in Dolby's SEC filings and reports, including the
risks identified under the section captioned "Risk Factors" in its
Annual Report on Form 10-K filed on or around the date hereof.
Dolby may not actually achieve the plans, intentions, or
expectations disclosed in its forward-looking statements.
Forward-looking statements are based upon information available to
us as of the date of such statements, and while Dolby believes such
information forms a reasonable basis for such statements, such
information may be limited or incomplete. These statements are
inherently uncertain and investors are cautioned not to unduly rely
upon these statements. Except as required by law, Dolby disclaims
any obligation to update information contained in these
forward-looking statements whether as a result of new information,
future events, or otherwise.
About Dolby Laboratories
Dolby Laboratories (NYSE: DLB) is based in San
Francisco, California with offices
around the globe. From movies and TV shows, to apps, music, sports
and gaming, Dolby transforms the science of sight and sound into
spectacular experiences for billions of people worldwide. Dolby
partners with artists, storytellers, developers, and businesses to
revolutionize entertainment and communications with
Dolby Atmos, Dolby Vision, Dolby Cinema, and
Dolby.io.
Dolby, Dolby Atmos, Dolby Vision, Dolby Cinema, Dolby.io, and
the double-D symbol are among the registered and unregistered
trademarks of Dolby Laboratories in the
United States and/or other countries. Other trademarks
remain the property of their respective owners.
DOLBY LABORATORIES,
INC.
CONSOLIDATED
STATEMENTS OF OPERATIONS
(in thousands,
except per share amounts; unaudited)
|
|
|
Fiscal Quarter
Ended
|
|
Fiscal Year
Ended
|
|
September
27,
2024
|
September
29,
2023
|
|
September
27,
2024
|
September
29,
2023
|
Revenue:
|
|
|
|
|
|
Licensing
|
$
282,705
|
$
265,203
|
|
$
1,181,794
|
$
1,197,930
|
Products and
services
|
22,101
|
25,359
|
|
91,927
|
101,814
|
Total
revenue
|
304,806
|
290,562
|
|
1,273,721
|
1,299,744
|
|
|
|
|
|
|
Cost of
revenue:
|
|
|
|
|
|
Cost of
licensing
|
18,764
|
14,556
|
|
67,204
|
64,890
|
Cost of products and
services
|
15,232
|
20,996
|
|
73,292
|
87,676
|
Total cost of
revenue
|
33,996
|
35,552
|
|
140,496
|
152,566
|
|
|
|
|
|
|
Gross
profit
|
270,810
|
255,010
|
|
1,133,225
|
1,147,178
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
Research and
development
|
68,636
|
70,426
|
|
263,663
|
271,523
|
Sales and
marketing
|
87,901
|
90,870
|
|
334,460
|
354,364
|
General and
administrative
|
69,209
|
66,612
|
|
270,392
|
258,477
|
Restructuring
charges/(credits)
|
(1,290)
|
30,596
|
|
6,384
|
47,061
|
Total operating
expenses
|
224,456
|
258,504
|
|
874,899
|
931,425
|
|
|
|
|
|
|
Operating
income/(loss)
|
46,354
|
(3,494)
|
|
258,326
|
215,753
|
|
|
|
|
|
|
Other
income/(expense):
|
|
|
|
|
|
Interest
income/(expense), net
|
6,854
|
9,280
|
|
34,077
|
28,086
|
Other income,
net
|
6,526
|
3,247
|
|
20,076
|
6,214
|
Total other
income
|
13,380
|
12,527
|
|
54,153
|
34,300
|
|
|
|
|
|
|
Income before income
taxes
|
59,734
|
9,033
|
|
312,479
|
250,053
|
(Provision
for)/benefit from income taxes
|
(868)
|
875
|
|
(48,163)
|
(48,409)
|
Net income including
noncontrolling interest
|
58,866
|
9,908
|
|
264,316
|
201,644
|
Less: net income
attributable to noncontrolling interest
|
(296)
|
(722)
|
|
(2,491)
|
(988)
|
Net income
attributable to Dolby Laboratories, Inc.
|
$
58,570
|
$
9,186
|
|
$
261,825
|
$
200,656
|
|
|
|
|
|
|
Net income per
share:
|
|
|
|
|
|
Basic
|
$
0.61
|
$
0.10
|
|
$
2.74
|
$
2.10
|
Diluted
|
$
0.61
|
$
0.09
|
|
$
2.69
|
$
2.05
|
Weighted-average shares
outstanding:
|
|
|
|
|
|
Basic
|
95,395
|
95,701
|
|
95,544
|
95,771
|
Diluted
|
96,593
|
97,678
|
|
97,325
|
97,733
|
DOLBY LABORATORIES,
INC.
CONSOLIDATED BALANCE
SHEETS
(in thousands;
unaudited)
|
|
|
September
27,
2024
|
September
29,
2023
|
ASSETS
|
|
|
Current
assets:
|
|
|
Cash and cash
equivalents
|
$
482,047
|
$
745,364
|
Restricted
cash
|
95,705
|
72,602
|
Short-term
investments
|
—
|
139,148
|
Accounts receivable,
net
|
315,465
|
262,245
|
Contract assets,
net
|
197,478
|
182,130
|
Inventories,
net
|
33,728
|
35,623
|
Prepaid expenses and
other current assets
|
69,994
|
50,692
|
Total current
assets
|
1,194,417
|
1,487,804
|
Long-term
investments
|
89,267
|
97,812
|
Property, plant, and
equipment, net
|
479,109
|
481,581
|
Operating lease
right-of-use assets
|
39,046
|
40,199
|
Goodwill and
intangible assets, net
|
967,722
|
575,836
|
Deferred
taxes
|
219,758
|
201,860
|
Other non-current
assets
|
120,609
|
94,674
|
Total
assets
|
$
3,109,928
|
$
2,979,766
|
|
|
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
Current
liabilities:
|
|
|
Accounts
payable
|
$
17,380
|
$
20,925
|
Accrued
liabilities
|
347,529
|
351,399
|
Income taxes
payable
|
9,045
|
4,769
|
Contract
liabilities
|
31,644
|
31,505
|
Operating lease
liabilities
|
12,238
|
13,628
|
Total current
liabilities
|
417,836
|
422,226
|
Non-current contract
liabilities
|
34,593
|
39,997
|
Non-current operating
lease liabilities
|
34,754
|
37,020
|
Other non-current
liabilities
|
135,852
|
108,339
|
Total
liabilities
|
623,035
|
607,582
|
|
|
|
Stockholders'
equity:
|
|
|
Class A common
stock
|
53
|
53
|
Class B common
stock
|
41
|
41
|
Retained
earnings
|
2,496,255
|
2,391,990
|
Accumulated other
comprehensive loss
|
(19,187)
|
(36,984)
|
Total stockholders'
equity – Dolby Laboratories, Inc.
|
2,477,162
|
2,355,100
|
Noncontrolling
interest
|
9,731
|
17,084
|
Total stockholders'
equity
|
2,486,893
|
2,372,184
|
Total liabilities
and stockholders' equity
|
$
3,109,928
|
$
2,979,766
|
DOLBY LABORATORIES,
INC.
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(in thousands;
unaudited)
|
|
|
Fiscal Year
Ended
|
|
September
27,
2024
|
September
29,
2023
|
Operating
activities:
|
|
|
Net income including
noncontrolling interest
|
$
264,316
|
$
201,644
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
Depreciation
and amortization
|
75,559
|
82,558
|
Stock-based
compensation
|
119,825
|
118,486
|
Amortization of
operating lease right-of-use assets
|
11,768
|
12,956
|
Amortization of
premium on investments
|
(2,919)
|
(860)
|
Benefit from
credit losses
|
(2,256)
|
(793)
|
Deferred income
taxes
|
(21,612)
|
(18,337)
|
Impairment loss
on internally developed software
|
—
|
16,225
|
Other non-cash
items affecting net income
|
(10,828)
|
(2,800)
|
Changes in
operating assets and liabilities:
|
|
|
Accounts receivable,
net
|
(28,967)
|
47,779
|
Contract assets,
net
|
(8,707)
|
347
|
Inventories
|
(2,654)
|
(13,226)
|
Operating lease
right-of-use assets
|
(8,420)
|
(8,817)
|
Prepaid expenses and
other assets
|
10,097
|
3,868
|
Accounts payable and
accrued liabilities
|
(34,554)
|
(52,315)
|
Income taxes,
net
|
(4,501)
|
(8,722)
|
Contract
liabilities
|
(9,738)
|
(8,379)
|
Operating lease
liabilities
|
(5,263)
|
(5,818)
|
Other non-current
liabilities
|
(13,894)
|
3,285
|
Net cash provided by
operating activities
|
327,252
|
367,081
|
|
|
|
Investing
activities:
|
|
|
Purchases of
marketable securities
|
(160,198)
|
(172,955)
|
Proceeds from sales of
marketable securities
|
234,061
|
54,964
|
Proceeds from
maturities of marketable securities
|
157,729
|
176,833
|
Purchases of property,
plant, and equipment
|
(30,007)
|
(30,339)
|
Business combinations,
net of cash and restricted cash acquired
|
(487,877)
|
25,703
|
Net cash provided
by/(used in) investing activities
|
(286,292)
|
54,206
|
|
|
|
Financing
activities:
|
|
|
Proceeds from issuance
of common stock
|
40,203
|
47,781
|
Repurchase of common
stock
|
(160,001)
|
(149,276)
|
Payment of cash
dividend
|
(114,579)
|
(103,407)
|
Distributions to
noncontrolling interest
|
(5,164)
|
(266)
|
Purchase of
noncontrolling interest in business combinations
|
(9,920)
|
—
|
Equity issued in
connection with business combination
|
722
|
—
|
Shares repurchased for
tax withholdings on vesting of restricted stock
|
(39,075)
|
(31,144)
|
Payment of deferred
consideration for prior business combinations
|
—
|
(500)
|
Net cash used in
financing activities
|
(287,814)
|
(236,812)
|
|
|
|
Effect of foreign
exchange rate changes on cash, cash equivalents, and restricted
cash
|
6,640
|
5,120
|
Net increase/(decrease)
in cash, cash equivalents, and restricted cash
|
(240,214)
|
189,595
|
Cash, cash equivalents,
and restricted cash at beginning of period
|
817,966
|
628,371
|
Cash, cash equivalents,
and restricted cash at end of period
|
$
577,752
|
$
817,966
|
Licensing Revenue by
Market (unaudited)
|
|
The following table
presents the composition of our licensing revenue and percentage of
total licensing revenue for all periods presented (in thousands,
except percentage amounts):
|
|
|
Fiscal Quarter
Ended
|
|
Fiscal Year
Ended
|
Market
|
September 27,
2024
|
|
September 29,
2023
|
|
September 27,
2024
|
|
September 29,
2023
|
Broadcast
|
$ 95,779
|
34 %
|
|
$
102,448
|
39 %
|
|
$
409,105
|
35 %
|
|
$ 451,719
|
38 %
|
Mobile
|
48,701
|
17 %
|
|
36,122
|
14 %
|
|
235,774
|
20 %
|
|
243,897
|
20 %
|
CE
|
42,024
|
15 %
|
|
41,682
|
16 %
|
|
165,817
|
14 %
|
|
170,197
|
14 %
|
PC
|
34,077
|
12 %
|
|
27,240
|
10 %
|
|
141,300
|
12 %
|
|
124,362
|
10 %
|
Other
|
62,124
|
22 %
|
|
57,711
|
21 %
|
|
229,798
|
19 %
|
|
207,755
|
18 %
|
Total licensing
revenue
|
$
282,705
|
100 %
|
|
$
265,203
|
100 %
|
|
$
1,181,794
|
100 %
|
|
$
1,197,930
|
100 %
|
GAAP to Non-GAAP
Reconciliations
|
(unaudited)
|
|
|
|
|
|
|
|
The following tables
present Dolby's GAAP financial measures reconciled to the non-GAAP
financial measures included in this release for the fourth quarter
and fiscal years ended September 27, 2024 and
September 29, 2023:
|
|
|
|
|
|
|
|
Net
income:
|
|
Fiscal Quarter
Ended
|
|
Fiscal Year
Ended
|
(in
thousands)
|
|
September
27,
2024
|
September
29,
2023
|
|
September
27,
2024
|
September
29,
2023
|
GAAP net income
attributable to Dolby Laboratories, Inc.
|
|
$
58,570
|
$
9,186
|
|
$
261,825
|
$
200,656
|
Stock-based
compensation (1)
|
|
29,679
|
28,195
|
|
119,825
|
118,486
|
Amortization of
acquisition-related intangibles (2)
|
|
6,296
|
3,306
|
|
15,552
|
10,056
|
Restructuring
charges/(credits)
|
|
(1,290)
|
30,596
|
|
6,384
|
47,061
|
Impact of Tax
Reform
|
|
(10,042)
|
—
|
|
(10,042)
|
—
|
Income tax
adjustments
|
|
(4,777)
|
(7,339)
|
|
(24,528)
|
(28,249)
|
Non-GAAP net income
attributable to Dolby Laboratories, Inc.
|
|
$
78,436
|
$
63,944
|
|
$
369,016
|
$
348,010
|
|
|
|
|
|
|
|
(1) Stock-based
compensation included in above line items:
|
|
|
|
|
|
|
Cost of products and
services
|
|
$
362
|
$
388
|
|
$
1,501
|
$
1,697
|
Research and
development
|
|
9,703
|
9,643
|
|
38,214
|
39,472
|
Sales and
marketing
|
|
9,994
|
9,279
|
|
40,128
|
40,038
|
General and
administrative
|
|
9,620
|
8,885
|
|
39,982
|
37,279
|
|
|
|
|
|
|
|
(2) Amortization of
acquisition-related intangibles included in above line
items:
|
|
|
|
|
|
|
Cost of
licensing
|
|
$
2,789
|
$
62
|
|
$
2,890
|
$
248
|
Cost of products and
services
|
|
768
|
650
|
|
2,350
|
3,248
|
Research and
development
|
|
—
|
—
|
|
—
|
253
|
Sales and
marketing
|
|
867
|
721
|
|
2,824
|
3,137
|
General and
administrative
|
|
1,872
|
1,873
|
|
7,488
|
3,170
|
|
|
|
|
|
|
|
Diluted earnings per
share:
|
|
Fiscal Quarter
Ended
|
|
Fiscal Year
Ended
|
|
|
September
27,
2024
|
September
29,
2023
|
|
September
27,
2024
|
September
29,
2023
|
GAAP diluted earnings
per share
|
|
$
0.61
|
$
0.09
|
|
$
2.69
|
$
2.05
|
Stock-based
compensation
|
|
0.30
|
0.29
|
|
1.23
|
1.21
|
Amortization of
acquisition-related intangibles
|
|
0.06
|
0.03
|
|
0.16
|
0.10
|
Restructuring
charges/(credits)
|
|
(0.01)
|
0.31
|
|
0.07
|
0.48
|
Impact of Tax
Reform
|
|
(0.10)
|
—
|
|
(0.11)
|
—
|
Income tax
adjustments
|
|
(0.05)
|
(0.07)
|
|
(0.25)
|
(0.28)
|
Non-GAAP diluted
earnings per share
|
|
$
0.81
|
$
0.65
|
|
$
3.79
|
$
3.56
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares
outstanding - diluted (in thousands)
|
|
96,593
|
97,678
|
|
97,325
|
97,733
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following tables
present a reconciliation between GAAP and non-GAAP versions of the
estimated financial measures for the first quarter of fiscal 2025
and full year fiscal 2025 included in this release:
|
|
|
|
|
|
|
|
Gross
margin:
|
|
|
Q1
2025
|
|
|
Fiscal
2025
|
GAAP gross
margin
|
|
|
87.0 %
|
|
|
87.0 %
|
Stock-based
compensation
|
|
|
0.1 %
|
|
|
0.1 %
|
Amortization of
acquisition-related intangibles
|
|
|
2.9 %
|
|
|
2.9 %
|
Non-GAAP gross
margin
|
|
|
90.0 %
|
|
|
90.0 %
|
|
|
|
|
|
|
|
Operating expenses
(in millions):
|
|
|
Q1
2025
|
|
|
Fiscal
2025
|
GAAP operating expenses
(low - high end of range)
|
|
|
$230 - $240
|
|
|
$908 - $918
|
Stock-based
compensation
|
|
|
(37)
|
|
|
(134)
|
Amortization of
acquisition-related intangibles
|
|
|
(3)
|
|
|
(9)
|
Non-GAAP operating
expenses (low - high end of range)
|
|
|
$190 - $200
|
|
|
$765 - $775
|
|
|
|
|
|
|
|
Operating
margin:
|
|
|
|
|
Fiscal
2025
|
GAAP operating
margin
|
|
|
|
|
|
20% +/-
|
Stock-based
compensation
|
|
|
|
|
|
10 %
|
Amortization of
acquisition-related intangibles
|
|
|
|
|
|
3 %
|
Non-GAAP operating
margin
|
|
|
|
|
|
33% +/-
|
|
|
|
|
|
|
|
Effective tax
rate:
|
|
|
|
|
|
Q1
2025
|
GAAP effective tax
rate
|
|
|
|
|
|
20.5 %
|
Stock-based
compensation (low - high end of range)
|
|
|
|
|
|
(2%) - 0%
|
Amortization of
acquisition-related intangibles (low - high end of
range)
|
|
|
|
|
|
(1%) - 0%
|
Non-GAAP effective tax
rate
|
|
|
|
|
|
18.5 %
|
|
|
|
|
|
|
|
Diluted earnings per
share:
|
|
Q1
2025
|
|
Fiscal
2025
|
|
|
Low
|
High
|
|
Low
|
High
|
GAAP diluted earnings
per share
|
|
$
0.53
|
$
0.68
|
|
$
2.43
|
$
2.58
|
Stock-based
compensation
|
|
0.39
|
0.39
|
|
1.39
|
1.39
|
Amortization of
acquisition-related intangibles
|
|
0.12
|
0.12
|
|
0.45
|
0.45
|
Income tax
adjustments
|
|
(0.08)
|
(0.08)
|
|
(0.28)
|
(0.28)
|
Non-GAAP diluted
earnings per share
|
|
$
0.96
|
$
1.11
|
|
$
3.99
|
$
4.14
|
|
|
|
|
|
|
|
Weighted-average shares
outstanding - diluted (in thousands)
|
|
97,400
|
97,400
|
|
97,500
|
97,500
|
Investor Contact:
Peter
Goldmacher
415-254-7415
peter.goldmacher@dolby.com
Media Contact:
media@dolby.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dolby-laboratories-reports-fourth-quarter-and-fiscal-year-2024-financial-results-302310222.html
SOURCE Dolby Laboratories, Inc.